Emerging drugs of abuse

ME Nelson, SM Bryant, SE Aks - Disease-a-Month, 2014 - Elsevier
Keeping up with emerging drugs of abuse will always be a challenge for physicians. As law
enforcement agencies classify certain drugs as illegal,“street pharmacists” rapidly adapt and …

Arylethylamine psychotropic recreational drugs: a chemical perspective

S Freeman, JF Alder - European Journal of Medicinal Chemistry, 2002 - Elsevier
The arylethylamines substituted in the aryl ring, side-chain carbons and on the terminal
amine, comprise a large number of human mood and behaviour altering chemicals. Some of …

Metabolic pathways of 4-bromo-2, 5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human

H Carmo, JG Hengstler, D De Boer, M Ringel… - Toxicology, 2005 - Elsevier
4-Bromo-2, 5-dimethoxyphenethylamine (2C-B) is a psychoactive designer drug of abuse
that is sold under the street names “Venus”,“Bromo”,“Erox”,“XTC” or “Nexus”. Concern has …

A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs

D de Boer, I Bosman - Pharmacy World and Science, 2004 - Springer
Objective: To collect data related to phenethylamine drugs-of-abuse of the 2C-series, to
review possible health risks of their use and to discuss legal counter actions of authorities in …

Prodrugs of new psychoactive substances (NPS): a new challenge

SP Elliott, T Holdbrook… - Journal of forensic …, 2020 - Wiley Online Library
The concept of a substance acting as a prodrug for an intended drug is not new and has
been known and utilized with particular benefits within medicine for efficacy and patient …

Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans

JJ Nugteren-van Lonkhuyzen, AJHP van Riel… - Drug and alcohol …, 2015 - Elsevier
Background Recently, the number of new psychoactive substances (NPS) appearing on the
illicit drug market has shown a marked increase. Although many users perceive the risk of …

4-Bromo-2, 5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects

F Caudevilla-Gálligo, J Riba… - Journal of …, 2012 - journals.sagepub.com
4-Bromo-2, 5-dimethoxyphenethylamine (2C-B) is a psychoactive analogue of mescaline
that is becoming increasingly popular as a rave and club drug. We investigated its presence …

1 H quantitative NMR and UHPLC-MS analysis of seized MDMA/NPS mixtures and tablets from night-club venues

HA Naqi, SM Husbands, IS Blagbrough - Analytical Methods, 2019 - pubs.rsc.org
3, 4-Methylenedioxymethamphetamine (MDMA) in the UK has increased in purity and the
contents sold as MDMA (ecstasy, E) have increased in complexity. Night-club scenes remain …

Cardiovascular toxicity of novel psychoactive drugs: lessons from the past

P Dawson, JD Moffatt - Progress in Neuro-Psychopharmacology and …, 2012 - Elsevier
The long use of ephedrine, amphetamines, cocaine, LSD and more recently 3, 4-
methylenedioxy-N-methylamphetamine (MDMA;“Ecstasy”) allows us to predict with some …

Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose

T Páleníček, M Balíková, V Bubeníková-Valešová… - …, 2008 - Springer
Rationale Mescaline is a nonselective serotonin receptor agonist. It has relatively delayed
onset of action and prolonged duration. Mescaline attenuates various behavioral …